Skip to main content
. 2023 Mar 8;25(4):166. doi: 10.3892/ol.2023.13751

Table II.

Clinicopathologic characteristics of the study population.

Category Diagnostic group (n=139) Non-diagnostic group (n=59) P-value
Sex 0.44
  Male, n (%) 72 (36.4) 27 (13.6)
  Female, n (%) 67 (33.8) 32 (16.2)
Mean age + SD, years 61.09±10.87 60.22±9.20 0.59
History of malignancy 0.50
  Yes, n (%) 8 (4.0) 4 (2.0)
  No, n (%) 131 (66.2) 55 (27.8)
Pathology results 0.19
  Benign, n (%) 20 (10.1) 13 (6.6)
  Malignancy, n (%) 119 (60.1) 46 (23.2)
Median nodule size, cm (IQS) 1.7 (1.2) 1.4 (1.0) <0.01
Nodule type <0.01
  Solid, n (%) 66 (33.3) 14 (7.0)
  Pure GGO, n (%) 7 (3.5) 11 (5.6)
  Mixed GGO, n (%) 66 (33.3) 34 (17.2)
Median CT value, Hu (IQS) −120 (−418) −270 (−432) <0.01
Median distance from pleura, cm (IQS) 0.80 (1.60) 1.00 (1.70) 0.12
Pleural contact 0.02
  Yes, n (%) 57 (28.8) 14 (7.1)
  No, n (%) 82 (41.4) 45 (22.7)
Bronchus sign 0.18
  Yes, n (%) 7 (3.5) 6 (3.0)
  No, n (%) 132 (66.7) 53 (26.8)
Nodule position 0.04
  Upper left lung, n (%) 25 (12.6) 20 (10.1)
  Lower left lung, n (%) 17 (8.6) 10 (5.1)
  Upper right lung, n (%) 55 (27.8) 14 (7.1)
  Middle lung, n (%) 18 (9.1) 4 (2.0)
  Right lower lung, n (%) 24 (12.1) 11 (5.6)

GGO, ground-glass opacity; IQS, interquartile spacing.